Các khái niệm đã thiết lập và mới nổi trong viêm ruột kết liên quan đến bệnh Hirschsprung

Hirschspring H (1888) Constipation in newborns due to dilation and hypertrophy of the colon. Jahrbuch Kinderheikunde Raffensperger JG (1987) Hirschsprung’s disease: a historical review. Bull Soc Sci Med Grand Duche Luxemb 124:31–36 Engum SA, Grosfeld JL (2004) Long-term results of treatment of Hirschsprung’s disease. Semin Pediatr Surg 13:273–285. doi:10.1053/j.sempedsurg.2004.10.015 Kenny SE, Tam PKH, Garcia-Barcelo M (2010) Hirschsprung’s disease. Semin Pediatr Surg 19:194–200. doi:10.1053/j.sempedsurg.2010.03.004 Baxter KJ, Bhatia AM (2013) Hirschsprung’s disease in the preterm infant: implications for diagnosis and outcome. Am Surg 79:734–738 Duess JW, Hofmann AD, Puri P (2014) Prevalence of Hirschsprung’s disease in premature infants: a systematic review. Pediatr Surg Int 30:791–795. doi:10.1007/s00383-014-3540-8 Downey EC, Hughes E, Putnam AR et al (2015) Hirschsprung disease in the premature newborn: a population based study and 40-year single center experience. J Pediatr Surg 50:123–125. doi:10.1016/j.jpedsurg.2014.10.013 Austin KM (2012) The pathogenesis of Hirschsprung’s disease-associated enterocolitis. YSPSU 21:319–327. doi:10.1053/j.sempedsurg.2012.07.006 Frykman PK, Short SS (2012) Hirschsprung-associated enterocolitis: prevention and therapy. YSPSU 21:328–335. doi:10.1053/j.sempedsurg.2012.07.007 Foster P, Cowan G, Wrenn EL (1990) Twenty-five years“experience with Hirschsprung”s disease. J Pediatr Surg 25:531–534 Rescorla FJ, Morrison AM, Engles D et al (1992) Hirschsprung’s disease. Evaluation of mortality and long-term function in 260 cases. Arch Surg 127:934–41 (discussion 941–2) Harrison MW, Deitz DM, Campbell JR, Campbell TJ (1986) Diagnosis and management of Hirschsprung’s disease. A 25 year perspective. AJS 152:49–56 Pini-Prato A, Rossi V, Avanzini S et al (2011) Hirschsprung’s disease: what about mortality? Pediatr Surg Int 27:473–478. doi:10.1007/s00383-010-2848-2 Dalkey N, Helmer O (1963) An experimental application of the Delphi method to the use of experts. Manag Sci 9:458–467 Pastor AC, Osman F, Teitelbaum DH et al (2009) Development of a standardized definition forHirschsprung’s-associated enterocolitis:a Delphi analysis. J Pediatr Surg 44:251–256. doi:10.1016/j.jpedsurg.2008.10.052 Brearly S, Armstrong GR, Nairn R et al (1987) Pseudomembranous colitis: a lethal complication of Hirschsprung’s disease unrelated to antibiotic usage. J Pediatr Surg 22:257–259 Marty TL, Seo T, Matlak ME et al (1995) Gastrointestinal function after surgical correction of Hirschsprung’s disease: long-term follow-up in 135 patients. J Pediatr Surg 30:655–658 Fujimoto T (1988) Natural history and pathophysiology of enterocolitis in the piebald lethal mouse model of Hirschsprung’s disease. J Pediatr Surg 23:237–242 Demehri FR, Halaweish IF, Coran AG, Teitelbaum DH (2013) Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention. Pediatr Surg Int 29:873–881. doi:10.1007/s00383-013-3353-1 Lyonnet S, Bolino A, Pelet A et al (1993) A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet 4:346–350. doi:10.1038/ng0893-346 Romeo G, Ronchetto P, Luo Y et al (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung’s disease. Nature 367:377–378. doi:10.1038/367377a0 Amiel J, Sproat-Emison E, Garcia-Barcelo M et al (2008) Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 45:1–14. doi:10.1136/jmg.2007.053959 Veiga-Fernandes H, Coles MC, Foster KE et al (2007) Tyrosine kinase receptor RET is a key regulator of Peyer’s Patch organogenesis. Nature 446:547–551. doi:10.1038/nature05597 Schuchardt A, D’Agati V, Larsson-Blomberg L et al (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367:380–383. doi:10.1038/367380a0 Nagy N, Goldstein AM (2006) Endothelin-3 regulates neural crest cell proliferation and differentiation in the hindgut enteric nervous system. Dev Biol 293:203–217. doi:10.1016/j.ydbio.2006.01.032 Gariepy CE, Cass DT, Yanagisawa M (1996) Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color. Proc Natl Acad Sci USA 93:867–872 Druckenbrod NR, Powers PA, Bartley CR et al (2008) Targeting of endothelin receptor-B to the neural crest. Genesis 46:396–400. doi:10.1002/dvg.20415 Cheng Z, Dhall D, Zhao L et al (2010) Murine model of Hirschsprung-associated enterocolitis.I: phenotypic characterization with development of ahistopathologic grading system. J Pediatr Surg 45:475–482. doi:10.1016/j.jpedsurg.2009.06.009 Zhao L, Dhall D, Cheng Z et al (2010) Murine model of Hirschsprung-associated enterocolitis II: surgical correction of aganglionosis does noteliminate enterocolitis. J Pediatr Surg 45:206–212. doi:10.1016/j.jpedsurg.2009.10.035 Cheng Z, Wang X, Dhall D et al (2010) Splenic lymphopenia in the endothelin receptor B-null mouse: implications for Hirschsprung associated enterocolitis. Pediatr Surg Int 27:145–150. doi:10.1007/s00383-010-2787-y Ward NL, Pieretti A, Dowd SE et al (2012) Intestinal aganglionosis is associated with early and sustained disruption of the colonic microbiome. Neurogastroenterol Motil 24:e400–e874. doi:10.1111/j.1365-2982.2012.01937.x Thiagarajah JR, Yildiz H, Carlson T et al (2014) Altered goblet cell differentiation and surface mucus properties in Hirschsprung disease. PLoS One 9:e99944. doi:10.1371/journal.pone.0099944.t001 Frykman PK, Cheng Z, Wang X, Dhall D (2015) Enterocolitis causes profound lymphoid depletion in endothelin receptor B- and endothelin 3-null mouse models of Hirschsprung-associated enterocolitis. Eur J Immunol 45:807–817. doi:10.1002/eji.201444737 Yildiz HM, Carlson TL, Goldstein AM, Carrier RL (2015) Mucus barriers to microparticles and microbes are altered in Hirschsprung’s disease. Macromol Biosci 15:712–718. doi:10.1002/mabi.201400473 Pierre JF, Barlow-Anacker AJ, Erickson CS et al (2014) Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung’s disease. J Pediatr Surg 49:1242–1251. doi:10.1016/j.jpedsurg.2014.01.060 Gosain A, Barlow-Anacker AJ, Erickson CS et al (2015) Impaired cellular immunity in the murine neural crest conditional deletion of endothelin receptor-B model of Hirschsprung’s disease. PLoS One 10:e0128822. doi:10.1371/journal.pone.0128822 Brandtzaeg P, Kiyono H, Pabst R, Russell MW (2008) Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 1:31–37. doi:10.1038/mi.2007.9 Craig SW, Cebra JJ (1971) Peyer’s patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med 134:188–200 Berlin C, Berg EL, Briskin MJ et al (1993) Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185–195 Berg EL, McEvoy LM, Berlin C et al (1993) L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 366:695–698. doi:10.1038/366695a0 Bowman EP, Kuklin NA, Youngman KR et al (2002) The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 195:269–275 Uren TK, Johansen F-E, Wijburg OLC et al (2003) Role of the polymeric Ig receptor in mucosal B cell homeostasis. J Immunol 170:2531–2539 Imamura A, Puri P, O’Briain DS, Reen DJ (1992) Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung’s disease. Gut 33:801–806. doi:10.1136/gut.33.6.801 Gosain A, Barlow-Anacker AJ, Erickson CS et al (2015) Impaired cellular immunity in the murine neural crest conditional deletion of endothelin receptor-B model of Hirschsprung’s disease. PLoS One 10:e0128822. doi:10.1371/journal.pone.0128822.s001 Rosado MM, Aranburu A, Capolunghi F et al (2009) From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol 2:351–361. doi:10.1038/mi.2009.15 Zhao L, Cheng Z, Dhall D et al (2009) A novel corrective pullthrough surgery in a mouse model of Hirschsprung’s disease. J Pediatr Surg 44:759–766. doi:10.1016/j.jpedsurg.2008.06.006 Keita ÅV, Söderholm JD (2010) The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 22:718–733. doi:10.1111/j.1365-2982.2010.01498.x Teitelbaum DH, Caniano DA, Qualman SJ (1989) The pathophysiology of Hirschsprung’s-associated enterocolitis: importance of histologic correlates. J Pediatr Surg 24:1271–1277 Aslam A, Spicer RD, Corfield AP (1997) Biochemical analysis of colonic mucin glycoproteins in children with Hirschsprung disease show disease specific alterations. Biochem Soc Trans 25:8S Mattar AF, Coran AG, Teitelbaum DH (2003) MUC-2 mucin production in Hirschsprung’s disease: possible association with enterocolitis development. J Pediatr Surg 38:417–421. doi:10.1053/jpsu.2003.50071 Karlsson J, Pütsep K, Chu H et al (2008) Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract. BMC Immunol 9:37. doi:10.1186/1471-2172-9-37 Alverdy J, Gilbert J, DeFazio JR et al (2014) Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health [corrected]. JPEN J Parenter Enteral Nutr 38:167–178. doi:10.1177/0148607113517904 De Filippo C, Pini-Prato A, Mattioli G et al (2010) Genomics approach to the analysis of bacterial communities dynamics in Hirschsprung’s disease-associated enterocolitis: a pilot study. Pediatr Surg Int 26:465–471. doi:10.1007/s00383-010-2586-5 Yan Z, Poroyko V, Gu S et al (2014) Biochemical and biophysical research communications. Biochem Biophys Research Commun 445:269–274. doi:10.1016/j.bbrc.2014.01.104 Frykman PK, Nordenskjöld A, Kawaguchi A et al (2015) Characterization of bacterial and fungal microbiome in children with Hirschsprung disease with and without a history of enterocolitis: a multicenter study. PLoS One 10:e0124172. doi:10.1371/journal.pone.0124172 Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603. doi:10.1038/35079107 Barreau F, Meinzer U, Chareyre F et al (2007) CARD15/NOD2 Is Required for Peyer’s Patches Homeostasis in Mice. PLoS ONE 2:e523. doi:10.1371/journal.pone.0000523.s004 Lacher M, Fitze G, Helmbrecht J et al (2010) Hirschsprung-associated enterocolitis develops independently of NOD2 variants. J Pediatr Surg 45:1826–1831. doi:10.1016/j.jpedsurg.2010.02.039 Moore SW, Sidler D, Zaahl MG (2008) The ITGB2 immunomodulatory gene (CD18), enterocolitis, and Hirschsprung’s disease. J Pediatr Surg 43:1439–1444. doi:10.1016/j.jpedsurg.2007.12.057 El-Sawaf M, Siddiqui S, Mahmoud M et al (2013) Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg 48:111–117. doi:10.1016/j.jpedsurg.2012.10.028 Wang X, Li Z, Xu Z et al (2015) Probiotics prevent Hirschsprung’s disease-associated enterocolitis: a prospective multicenter randomized controlled trial. Int J Colorectal Dis 30:105–110. doi:10.1007/s00384-014-2054-0